Daniel Birnbaum

50.4k citations
564 papers · 33.1k · 7 hit papers · h-index 94

Impact in

  • Cancer Research top 0.05%
    • Cancer Genomics and Diagnostics
    • Breast Cancer Treatment Studies
  • Oncology top 0.05%
    • Cancer Cells and Metastasis
    • Cancer-related Molecular Pathways

Papers in

    • Fibroblast Growth Factor Research 50
    • Gene expression and cancer classification 38
    • Cancer Cells and Metastasis 42
    • HER2/EGFR in Cancer Research 31

Daniel Birnbaum

544 papers receiving 32.0k citations

Daniel Birnbaum's Hit Papers

Salinomycin kills cancer stem cells by sequestering iron in lysosomes 2017 · 486 citations
4860+6+12Years since publication10002.0k3.0k

Peers

Daniel Birnbaum
Comparison fields: 5 of 171
  • Cancer Research 6.6k
  • Oncology 11.7k
  • Hematology 3.9k
  • Genetics 2.7k
  • Molecular Biology 16.3k
Replace William C. Hahn with:
William C. Hahn United States
Hong Wu United States
Martine F. Roussel United States
Jon C. Aster United States
A. Thomas Look United States
Michael F. Clarke United States
Alan D. D’Andrea United States
Lynda Chin United States
Daniel J. Hicklin United States
Frédéric J. de Sauvage United States
Daniel Birnbaum relative to William C. Hahn United States William C. Hahn's profile →
Citations per field
00.5×1.5×2.3×
William C. Hahn · 1×
Citations per year

Countries citing papers authored by Daniel Birnbaum

Since Specialization
Citations

This map shows the geographic impact of Daniel Birnbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Birnbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Birnbaum more than expected).

Fields of papers citing papers by Daniel Birnbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Birnbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Birnbaum. The network helps show where Daniel Birnbaum may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Birnbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Birnbaum Line = papers co-authored together Daniel Birnbaum links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 564 papers — load more, or switch the sort, to bring in the rest.

#Work
1
ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome
Hit paper breakdown →
20073284
2
Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
Hit paper breakdown →
2009975
3
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
Hit paper breakdown →
2010617
4
Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
Hit paper breakdown →
2009604
5
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
Hit paper breakdown →
2011531
6
Salinomycin kills cancer stem cells by sequestering iron in lysosomes
Hit paper breakdown →
2017486
7
The ExAC browser: displaying reference data information from over 60 000 exomes
Hit paper breakdown →
2016472
8 2005458
9 2009424
10 2014415
11 2008375
12 1983343
13 1993288
14
Characterization of the HST-related FGF.6 gene, a new member of the fibroblast growth factor gene family.
1989279
15 2000265
16
Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family.
1991262
17 1999257
18 2006238
19 2011228
20 2007225

About Daniel Birnbaum

Daniel Birnbaum is a scholar working on Molecular Biology, Oncology, Cancer Research, Genetics and Hematology, having authored 564 papers that have together received 33.1k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (50 papers), Cancer Genomics and Diagnostics (46 papers), Cancer Cells and Metastasis (42 papers), Breast Cancer Treatment Studies (40 papers), Acute Myeloid Leukemia Research (39 papers), Gene expression and cancer classification (38 papers), Genomic variations and chromosomal abnormalities (35 papers) and HER2/EGFR in Cancer Research (31 papers). The work is most often cited by research in Cancer Research (6.6k citations), Oncology (11.7k citations), Hematology (3.9k citations), Genetics (2.7k citations) and Molecular Biology (16.3k citations). Daniel Birnbaum has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include François Bertucci, Emmanuelle Charafe‐Jauffret, Pascal Finetti, Patrice Viens, Christophe Ginestier, José Adélaı̈de, Jocelyne Jacquemier, Olivier Rosnet, Max S. Wicha and Max Chaffanet. Their work appears in journals such as Oncogene, Genes Chromosomes and Cancer, Cancer Research, International Journal of Oncology and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact